Mission
The Beljanski Foundation continues Working to Cure Cancer the Natural Way by expanding the scientific research of Dr. Mirko Beljanski to find non-toxic, natural solutions to cancer.
Ruling year
2001
Founder
Sylvie Beljanski
Main address
317 East 53rd Street
New York, NY 10022 USA
EIN
13-4086570
NTEE code
Cancer (G30)
Cancer Research (H30)
Fund Raising and/or Fund Distribution (H12)
IRS filing requirement
This organization is required to file an IRS Form 990 or 990-EZ.
Sign in or create an account to view Form(s) 990 for 2019, 2018 and 2014.
Register now
Communication
Programs and results
What we aim to solve
The Beljanski Foundation is dedicated to funding research for natural, non-toxic answers to cancer by continuing the work of accomplished French molecular biologist, Dr. Mirko Beljanski. For over 40 years, Dr. Beljanski studied the environmental impact on DNA replication and transcription. The Beljanski Foundation carries out its mission in the following ways: • Fund research of our specific scientific studies on natural, non toxic cures to cancer and other chronic diseases • Host fundraising events and building a donor base • Raise funds, celebrate achievements and awareness • Grant giving to Educational Institutions • Engage the public about The Beljanski Foundation through educational events and sponsorships
Our programs
What are the organization's current programs, how do they measure success, and who do the programs serve?
Research Programs
Ongoing efforts to find natural, non-toxic extracts to fight cancer
Where we work
External reviews
Videos
Our Sustainable Development Goals
Learn more about Sustainable Development Goals.
Goals & Strategy
Learn about the organization's key goals, strategies, capabilities, and progress.
Charting impact
Four powerful questions that require reflection about what really matters - results.
What is the organization aiming to accomplish?
The foundation intends to raise money to fund further research to help cure cancer the natural way. We wish to expand the audience we reach and increase the number of partners we have who share in our commitment to keep building upon the discoveries of Dr. Mirko Beljanski, and share the results with as many people as possible.
What are the organization's key strategies for making this happen?
We will hold an annual fundraiser as well as a series of educational events when guests who come to hear from various health experts about a number of issues and solutions offered within the realm of conventional and integrative approaches. Guests who come to The Beljanski Foundation Fundraiser will be the first to hear of the latest updates regarding research programs funded by The Beljanski Foundation , and will be able to suggest and FUND future research.
What are the organization's capabilities for doing this?
The Beljanski Foundation is very confident in being able to accomplish our goals of furthering research programs to help support cancer patients in natural and nontoxic ways. We have been working relentlessly to establish partnerships with renowned academic entities and get all the results published in peer-reviewed papers. Currently those partnerships have led to published papers on precancerous cells, cancerous cells, advanced cancerous cells, cancer stem cells, and chemotherapy. Over the past twenty years we have partnered with a number of well-established organizations such as:
• Columbia University
• Kansas University Medical Center
• Nanjing University
• Cancer Treatment Centers of America
What have they accomplished so far and what's next?
Here is the research programs that the Foundation has already completed in partnership with various academic entities, and we are working endlessly to bring more scientifically proven data and share it with the public.
Precancerous Cells
• Rauwolfia vomitoria and Pao pereira reduce high PSA (prostate inflammation marker) levels in men
Two Herbal Extracts for Protecting Prostate Cell DNA. Burchill M. Integrative Medicine. 2010;9(2):32-36.
Cancerous Cells
• Rauwolfia vomitoria extract against prostate cancer
Anti-prostate cancer activity of β-carboline alkaloid enriched extract from Rauwolfia vomitoria. Bemis DL, Capodice JL, Gorroochurn P, Katz AE, Buttyan R. International Journal of Oncology. 2006;29:1065- 1073.
• Pao pereira extract against prostate cancer
β-Carboline Alkaloid-Enriched Extract from the Amazonian Rain Forest Tree Pao Pereira Suppresses Prostate Cancer Cells. Bemis DL, Capodice JL, Desai M, Katz AE, Buttyan R. Journal of the Society for Integrative Oncology. 2009;7(2):59-65.
• Pao pereira extract against ovarian cancer
The plant extract of Pao pereira potentiates carboplatin effects against ovarian cancer. Yu J, Chen Q. Pharmaceutical Biology. 2014;52(1):36-43.
• Rauwolfia vomitoria extract against ovarian cancer
Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer. Yu J, Ma Y, Drisko J, Chen Q. Current Therapeutic Research. 2013;75:8-14.
• Pao pereira extract against pancreatic cancer
Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira. Yu J, Drisko J, Chen Q. Oncology Reports. 2013;30(1):149-156.
• Rauwolfia vomitoria extract against pancreatic cancer
Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer. Yu J, Chen Q. Integrative Cancer Therapies. 2014;13(3): 217-225.
Advanced Cancer Cells
• Pao pereira extract against advanced prostate cancer
Pao Pereira Extract Suppresses Castration-Resistant Prostate Cancer Cell Growth, Survival, and Invasion Through Inhibition of NFκB Signaling. Chang C, Zhao W, Xie B, et al. Integrative Cancer Therapies. 2014;13(3):217-225.
Cancer Stem Cells
• Pao pereira extract against pancreatic cancer stem cells
Extract of the Medicinal Plant Pao Pereira Inhibits Pancreatic Cancer Stem-Like Cell In Vitro and In Vivo. Dong R, Chen P, Chen Q. Integrative Cancer Therapies. 2018;17(4):1204-1215.
• Rauwolfia vomitoria extract against pancreatic cancer stem cells
Inhibition of pancreatic cancer stem cells by Rauwolfia vomitoria extract. Dong R, Chen P, Chen Q. Oncology Reports. 2018;40:3144-3154.
Chemotherapy
• Immune support for white blood cells and platelets
Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia. Levin RD, Daehler M, Grutsch JF, Hall JL, Gupta D, Lis CG. BMC Cancer. 2010;10(1):1-8.
More research is still underway regarding autism and melanoma.
Financials
Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more
about GuideStar Pro.
Operations
The people, governance practices, and partners that make the organization tick.
Connect with nonprofit leaders
SubscribeBuild relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.
Connect with nonprofit leaders
SubscribeBuild relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.
Beljanski Foundation Inc
Board of directorsas of 6/29/2021
Jeanne M Stafford
The Beljanski Foundation
Term: 2019 -
Jeanne Stafford
Jacob Jaskiewicz
Sylvie Beljanski
Monique Beljanski
Dr. John Hall
Pierrette Weidlich
Board leadership practices
GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.
-
Board orientation and education
Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes -
CEO oversight
Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes -
Ethics and transparency
Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes -
Board composition
Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes -
Board performance
Has the board conducted a formal, written self-assessment of its performance within the past three years? Yes
Organizational demographics
Who works and leads organizations that serve our diverse communities? GuideStar partnered on this section with CHANGE Philanthropy and Equity in the Center.
Leadership
The organization's leader identifies as:
Race & ethnicity
No data
Gender identity
No data
No data
Sexual orientation
No data
Disability
No data
Thanks for signing up!
An email has been sent to the address you provided. Click on the link in that email to get more GuideStar Nonprofit Profile data today!
(Don't see an email in your inbox? Click here to resend it.)
GuideStar Pro Reports
Report successfully added to your cart!
Want more data?
A GuideStar Pro report containing the following information is available for this organization:
- Email contact information
- Financial trends metrics for five most recent years 2019, 2018, 2012, 2011*
- Financial statements for 2019, 2017
- Letter of Determination
- Officer and/or Employee data for 2019, 2018, 2012, 2011
- Contractor and/or Paid Preparer data for 2019, 2018, 2012
- Board of Directors data for 2021
- *with the ability to download the data for 2019, 2018, 2012, 2011
Download it now for $125.
Need the ability to download nonprofit data and more advanced search options?Consider a Pro Search subscription.